Literature DB >> 15426091

Multiple myeloma; a study of 24 patients treated with radioactive isotopes (P32 and SR89).

J H LAWRENCE, L R WASSERMAN.   

Abstract

Entities:  

Keywords:  PHOSPHORUS AND COMPOUNDS, RADIOACTIVE; STRONTIUM, RADIOACTIVE; TUMOR

Mesh:

Substances:

Year:  1950        PMID: 15426091     DOI: 10.7326/0003-4819-33-1-41

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  [DURATION OF DISEASE AND SURVIVAL TIME IN MULTIPLE MYELOMA].

Authors:  P OBRECHT; E KALLITERAKIS; D KLEMM
Journal:  Klin Wochenschr       Date:  1963-09-15

2.  Multiple myeloma.

Authors:  W A SKOOG; W S ADAMS
Journal:  Calif Med       Date:  1963-08

Review 3.  Strategies for management of prostate cancer-related bone pain.

Authors:  R C Pelger; V Soerdjbalie-Maikoe; N A Hamdy
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  [Life prognosis of treated and non-treated patients with plasmacytoma].

Authors:  C Ramsbott; H Gerhartz; P Obrecht
Journal:  Blut       Date:  1967-01

5.  89Strontium therapy of bone metastases of carcinoma of the prostatic gland.

Authors:  H J Correns; M Mebel; K Buchali; D Schnorr; C Seidel; E Mitterlechner
Journal:  Eur J Nucl Med       Date:  1979-02-01

6.  Strontium 89 for palliation of bone metastases.

Authors:  E K Reddy; R G Robinson; C M Mansfield
Journal:  J Natl Med Assoc       Date:  1986-01       Impact factor: 1.798

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.